...
首页> 外文期刊>The Endocrinologist >The Effect of Atorvastatin Treatment on Insulin Resistance, Leptin, and Highly Sensitive C-Reactive Protein in Hypercholesterolemic Patients
【24h】

The Effect of Atorvastatin Treatment on Insulin Resistance, Leptin, and Highly Sensitive C-Reactive Protein in Hypercholesterolemic Patients

机译:阿托伐他汀治疗对高胆固醇血症患者的胰岛素抵抗,瘦素和高敏感性C反应蛋白的影响

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this study was to evaluate the effect of atorvastatin treatment on insulin resistance, highly sensitive C-reactive protein, and leptin levels in hypercholesterolemic patients. Forty-two hypercholesterolemic and 24 control subjects were included in this study. Serum lipids, insulin, glucose, leptin, highly sensitive C-reactive protein, and homeostasis model assessment (HOMA-IR) were determined at baseline and after 3 months' atorvastatin treatment. Only high sensitive C-reactive protein level was decreased after treatment with atorvastatin in patients with hypercholesterolemia. These findings suggest that atorvastatin may be used as a therapy for improving the plasma lipids profile, as well as the chronic low-grade inflammatory state, in hypercholesterolemia.
机译:这项研究的目的是评估高胆固醇血症患者中阿托伐他汀治疗对胰岛素抵抗,高敏C反应蛋白和瘦素水平的影响。这项研究包括42名高胆固醇血症和24名对照受试者。在基线和阿托伐他汀治疗3个月后测定血清脂质,胰岛素,葡萄糖,瘦素,高敏C反应蛋白和体内稳态模型评估(HOMA-IR)。高胆固醇血症患者使用阿托伐他汀治疗后仅降低了高敏感性C反应蛋白水平。这些发现表明,在高胆固醇血症中,阿托伐他汀可以用作改善血浆脂质谱以及慢性低度炎症状态的疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号